NexgenRx Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was CAD 3.42 million compared to CAD 3.11 million a year ago. Net loss was CAD 0.008587 million compared to net income of CAD 0.030068 million a year ago.
For the six months, revenue was CAD 6.88 million compared to CAD 6.29 million a year ago. Net income was CAD 0.18634 million compared to CAD 0.408024 million a year ago. Basic earnings per share from continuing operations was CAD 0.003 compared to CAD 0.006 a year ago. Diluted earnings per share from continuing operations was CAD 0.002 compared to CAD 0.005 a year ago.